On Thursday the Swiss medicines regulator Swissmedic released data on side effects of Covid-19 vaccines as of March 8. While women were clearly more affected by the jabs, overall the majority of reports (70%) were not serious. Of the minority that were classified as serious the most common adverse reactions were fever (24), shortness of breath (18), Covid-19 disease (14), vomiting (11), hypersensitivity (11), anaphylactic reactions (8), headache/migraine (11) and reactivation of shingles (8).
A total of 21 people died at various intervals after receiving the vaccine. However, their average age was 85 and the majority had pre-existing conditions.
“As far as is known at present, death was caused by conditions such as infections, cardiovascular events or diseases of the lungs and airways that occurred independently of the vaccination. Despite a chronological correlation, there is no concrete evidence to suggest that the vaccination was the cause of death,” said an official statement.
There was not much of a difference between the two vaccines administered in the country when it came to side effects. Pfizer/BioNTech’s Comirnaty accounted for 343 adverse reaction reports while Moderna’s vaccine was responsible for 251. The AstraZeneca vaccine has not yet been approved by Swissmedic.
Overall, the medicines regulator said the data on adverse reactions was within the norm and no new worrying trends were identified.
“The reports corroborate the side effects profile identified during the authorisation studies and described in the medicinal product information. There is no evidence to date of any new safety signals, so the positive ratio of benefits to risks of the two authorised vaccines is still the same,” said the authorities.
External Content
Most Read Swiss Abroad
More
The citizenship obstacle course facing spouses of Swiss Abroad
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.